Legal

Pomerantz says class action filed against Capricor over Deramiocel FDA disclosures

Atlas Watchline · September 3, 2026

Key facts

What happened

Pomerantz LLP announced that a class action lawsuit has been filed against Capricor Therapeutics, Inc

Key facts

Why it matters

Capricor trades on NASDAQ under ticker CAPR

Key facts

The details

The case concerns whether Capricor and certain officers and/or directors engaged in securities fraud or other…

Atlas Watchline

Read the full report

Pomerantz LLP says investors who bought Capricor securities during the class period have until Sept. 28,…

Read on Atlas Watchline

Read on Atlas Watchline